Skip to search.
 BSE Up0.12% NSE Up0.15%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS

15.22 Down 0.18(1.20%) 1:25AM - Nasdaq Real Time Price

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.3
Mean Recommendation (last week):1.3
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:16.86
Median Target:16.00
High Target:20.00
Low Target:14.00
No. of Brokers:7

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
04-Apr-2012Cantor FitzgeraldInitiated Buy
17-May-2011OppenheimerInitiated Outperform
01-Oct-2010WedbushInitiated Outperform
25-Feb-2010Roth CapitalInitiated Buy
29-Sep-2009WBB SecuritiesInitiated Strong Buy
19-Dec-2008NeedhamDowngradeBuyHold
24-Oct-2008Merriman Curhan FordInitiated Buy
Data provided by Briefing.com

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy6665
Buy2222
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.